Crispr Therapeutics shares owned by Bourgeon Capital Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Bourgeon Capital Management
from 13F filings
Historical chart of Bourgeon Capital Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Bourgeon Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Bourgeon Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $266k | 5.6k | 47.57 |
| 2023-12-31 | $34k | 550 | 62.60 |
| 2023-09-30 | $2.3k | 50 | 45.40 |
| 2023-06-30 | $2.8k | 50 | 56.14 |
| 2023-03-31 | $93k | 2.1k | 45.23 |
| 2022-12-31 | $20k | 500 | 40.65 |
| 2022-09-30 | $33k | 500 | 66.00 |
| 2022-06-30 | $30k | 500 | 60.00 |
| 2022-03-31 | $113k | 1.8k | 62.78 |
| 2021-12-31 | $80k | 1.1k | 76.19 |
| 2021-09-30 | $62k | 550 | 112.73 |
| 2020-12-31 | $15k | 100 | 150.00 |
More positions owned by Bourgeon Capital Management
View all positions for Bourgeon Capital Management